Less than 50% of asthma patients feel their condition is well managed, Economist Impact study finds

By
Media Outreach
-
0

A new study and survey by Economist Impact, with the support of GSK, shows the continuing work that needs to be done to improve quality of life for people living with asthma.

LONDON, UNITED KINGDOM – is an Economist Impact report, with the support of GSK. This report aims to examine the different opportunities and challenges that adult patients with asthma face, while exploring the role that health systems, local and international guidelines, and contextual factors like comorbidities and provider-patient relationships play in shaping these experiences. Our research combined an evidence and literature review, two expert panel meetings, a patient survey spanning 13 countries (Australia, Brazil, Canada, China, France, Italy, Mexico, Philippines, South Africa, Spain, Thailand, Turkey, UK), and in-depth interviews. The report is launched at the on a panel discussion on September 6th, 2022, speakers include:

  • Olivia Fulton, research and policy volunteer, Asthma UK and the British Lung Foundation, UK
  • Dr Nicole Hass, PhD, MPH, MBS, MSc patient access and stakeholder engagement, Spain
  • Dr Kim Lavoie, PhD, FCPA, FABMR co-director, Montreal Behavioural Medicine Centre, Canada
  • Moderated by Rob Cook, clinical director, Health Policy and Insights, Economist Impact

About Economist Impact

Economist Impact combines the rigour of a think-tank with the creativity of a media brand to engage a globally influential audience. We believe that evidence-based insights can open debate, broaden perspectives and catalyse progress. The services offered by Economist Impact previously existed within The Economist Group as separate entities, including EIU Thought Leadership, EIU Public Policy, Economist Events and SignalNoise.

Our track record spans 75 years across 205 countries. Along with creative storytelling, events expertise, design-thinking solutions and market-leading media products, we produce framework design, benchmarking, economic and social impact analysis, forecasting and scenario modelling, making Economist Impact’s offering unique in the marketplace. Visit for more information.

About GSK

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. For more information, please visit .